121 related articles for article (PubMed ID: 11397708)
1. Point mutation (-69 G-->A) in the promoter region of cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects.
Nagano M; Yamashita S; Hirano K; Kujiraoka T; Ito M; Sagehashi Y; Hattori H; Nakajima N; Maruyama T; Sakai N; Egashira T; Matsuzawa Y
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):985-90. PubMed ID: 11397708
[TBL] [Abstract][Full Text] [Related]
2. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay.
Nagano M; Yamashita S; Hirano K; Ito M; Maruyama T; Ishihara M; Sagehashi Y; Oka T; Kujiraoka T; Hattori H; Nakajima N; Egashira T; Kondo M; Sakai N; Matsuzawa Y
J Lipid Res; 2002 Jul; 43(7):1011-8. PubMed ID: 12091484
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia.
Maruyama T; Sakai N; Ishigami M; Hirano K; Arai T; Okada S; Okuda E; Ohya A; Nakajima N; Kadowaki K; Fushimi E; Yamashita S; Matsuzawa Y
Atherosclerosis; 2003 Jan; 166(1):177-85. PubMed ID: 12482565
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
Yamashita S; Hirano K; Sakai N; Matsuzawa Y
Biochim Biophys Acta; 2000 Dec; 1529(1-3):257-75. PubMed ID: 11111094
[TBL] [Abstract][Full Text] [Related]
5. A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects.
Arai T; Yamashita S; Sakai N; Hirano K; Okada S; Ishigami M; Maruyama T; Yamane M; Kobayashi H; Nozaki S; Funahashi T; Kameda-Takemura K; Nakajima N; Matsuzawa Y
J Lipid Res; 1996 Oct; 37(10):2145-54. PubMed ID: 8906592
[TBL] [Abstract][Full Text] [Related]
6. Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population--relation between the mutation and hyperalphalipoproteinemia.
Hirano K; Yamashita S; Funahashi T; Sakai N; Menju M; Ishigami M; Hiraoka H; Kameda-Takemura K; Tokunaga K; Hoshino T
Atherosclerosis; 1993 Apr; 100(1):85-90. PubMed ID: 8318066
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese.
Nagano M; Yamashita S; Hirano K; Takano M; Maruyama T; Ishihara M; Sagehashi Y; Kujiraoka T; Tanaka K; Hattori H; Sakai N; Nakajima N; Egashira T; Matsuzawa Y
J Atheroscler Thromb; 2004; 11(3):110-21. PubMed ID: 15256762
[TBL] [Abstract][Full Text] [Related]
8. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase.
Hirano K; Yamashita S; Kuga Y; Sakai N; Nozaki S; Kihara S; Arai T; Yanagi K; Takami S; Menju M
Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1849-56. PubMed ID: 7583564
[TBL] [Abstract][Full Text] [Related]
9. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.
Hirano K; Yamashita S; Nakajima N; Arai T; Maruyama T; Yoshida Y; Ishigami M; Sakai N; Kameda-Takemura K; Matsuzawa Y
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1053-9. PubMed ID: 9194754
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.
Yamashita S; Maruyama T; Hirano K; Sakai N; Nakajima N; Matsuzawa Y
Atherosclerosis; 2000 Oct; 152(2):271-85. PubMed ID: 10998455
[TBL] [Abstract][Full Text] [Related]
11. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects.
Sakai N; Yamashita S; Hirano K; Menju M; Arai T; Kobayashi K; Ishigami M; Yoshida Y; Hoshino T; Nakajima N
Atherosclerosis; 1995 Apr; 114(2):139-45. PubMed ID: 7605382
[TBL] [Abstract][Full Text] [Related]
12. Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects.
Ohtani R; Inazu A; Noji Y; Wakasugi T; Miwa K; Tada H; Kawashiri MA; Noguchi T; Nohara A; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
Clin Chim Acta; 2012 Mar; 413(5-6):537-43. PubMed ID: 22122993
[TBL] [Abstract][Full Text] [Related]
13. [Serum apolipoprotein E-rich HDL-C levels in the subjects with hyperalphalipoproteinemia].
Inano K; Miida T; Okada M
Rinsho Byori; 1997 Sep; 45(9):903-7. PubMed ID: 9311266
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia.
Inazu A; Koizumi J; Haraki T; Yagi K; Wakasugi T; Takegoshi T; Mabuchi H; Takeda R
Hum Genet; 1993 Mar; 91(1):13-6. PubMed ID: 8454281
[TBL] [Abstract][Full Text] [Related]
15. Roles of plasma lipid transfer proteins in reverse cholesterol transport.
Yamashita S; Sakai N; Hirano K; Ishigami M; Maruyama T; Nakajima N; Matsuzawa Y
Front Biosci; 2001 Mar; 6():D366-87. PubMed ID: 11229884
[TBL] [Abstract][Full Text] [Related]
16. Novel mutations of CETP gene in Italian subjects with hyperalphalipoproteinemia.
Cefalù AB; Noto D; Magnolo L; Pinotti E; Gomaraschi M; Martini S; Vigna GB; Calabresi L; Tarugi P; Averna MR
Atherosclerosis; 2009 May; 204(1):202-7. PubMed ID: 18926541
[TBL] [Abstract][Full Text] [Related]
17. Two novel mutations and functional analyses of the CETP and LIPC genes underlying severe hyperalphalipoproteinemia.
Plengpanich W; Siriwong S; Khovidhunkit W
Metabolism; 2009 Aug; 58(8):1178-84. PubMed ID: 19428034
[TBL] [Abstract][Full Text] [Related]
18. Characterization of two HDL subfractions and LpA-I, LpA-I:A-II distribution profiles and clinical characteristics of hyperalphalipoproteinemic subjects without cholesterol ester transfer protein deficiency.
Sich D; Saïdi Y; Giral P; Lagrost L; Dallongeville J; Federspiel MC; Cherfils C; Raisonnier A; Turpin G; Beucler I
Atherosclerosis; 1998 Jun; 138(2):351-60. PubMed ID: 9690919
[TBL] [Abstract][Full Text] [Related]
19. [New approach to pathogenesis of genetic hyperlipoproteinemias].
Koizumi J; Inazu A; Mabuchi H
Rinsho Byori; 1993 May; 41(5):519-26. PubMed ID: 8350515
[TBL] [Abstract][Full Text] [Related]
20. A delayed-addition enzyme immunoassay for the relative cholesteryl ester transfer protein mass in patients with deficient plasma cholesteryl ester transfer activity.
Yamashita S; Sprecher DL; Matsuzawa Y; Sakai N; Tarui S; Harmony JA; Wetterau JR
Clin Chim Acta; 1990 Dec; 194(2-3):145-59. PubMed ID: 2093468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
